10 results
8-K
EX-10.1
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
such redemption, and to no other corporate purpose, except to the extent prohibited by Delaware law governing distributions to stockholders. The date
424B5
np5oq
3 Oct 13
Prospectus supplement for primary offering
12:00am
424B2
t4kklpul9p3t2o i10o
4 Oct 13
Prospectus for primary offering
12:00am
424B5
nrmsk
29 Apr 13
Prospectus supplement for primary offering
12:00am
424B2
lvhp n2xg1wxy7mqb3v
30 Apr 13
Prospectus for primary offering
12:00am
- Prev
- 1
- Next